Genentech joins efforts to raise awareness for lupus through annual walk.

  • Genentech is named national presenting sponsor of Walk to End Lupus Now.
  • The sponsorship aims to enhance global lupus awareness.
  • Funds raised will support lupus research and family outreach programs.

The Lupus Foundation of America has announced Genentech as the national presenting sponsor for the Walk to End Lupus Now. This annual event focuses on raising awareness and funds to combat lupus, a chronic autoimmune disease. The partnership signifies a commitment to improving the lives of those affected by lupus through increased support and resources.

As the presenting sponsor, Genentech will play a crucial role in the preparations for the upcoming walk, which is set to take place in multiple locations. The funds generated will contribute to research initiatives and outreach programs aimed at providing support to families impacted by lupus. This collaboration underscores the growing commitment towards enhancing lupus awareness and advancing research efforts.

The Walk to End Lupus Now serves as a platform for the lupus community to unite, share their stories, and promote advocacy. With Genentech's involvement, the event aims to reach new heights in engagement and fundraising, ultimately benefiting those living with lupus.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation

Innovative automation enhances cancer research and immunological studies. AI-powered tools improve research…

Pharmacelera Raises $6M to Expand in US and Enhance Drug Discovery Platform

Funding will support growth and technological advancements in drug discovery. Pharmacelera has…

NUNM Receives $1.5 Million Gift to Support Campus Expansion and Future Integrative Medicine Center

Major donation aims to enhance educational opportunities at NUNM. NUNM receives a…

WuXi Biologics and Vertex Enter Research Agreement for T-Cell Engager

Collaboration focuses on advancing T-cell engager therapies for cancer treatment WuXi Biologics…